Invention Application
- Patent Title: IGFBP7 RATIO FOR HFpEF
-
Application No.: US17613353Application Date: 2020-05-22
-
Publication No.: US20220229075A1Publication Date: 2022-07-21
- Inventor: Kai HABBEN , Vinzent ROLNY , Anika MANG , Ursula-Henrike WIENHUES-THELEN , Serge MASSON
- Applicant: Roche Diagnostics Operations, Inc.
- Applicant Address: US IN Indianapolis
- Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee Address: US IN Indianapolis
- Priority: EP19176160.0 20190523
- International Application: PCT/EP2020/064276 WO 20200522
- Main IPC: G01N33/74
- IPC: G01N33/74 ; G01N33/68

Abstract:
The present invention relates to a method for differentiating between heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF) in a subject suffering from heart failure, said method comprising the steps of determining the amounts of IGFBP7 (Insulin-like growth factor-binding protein 7), of a BNP-type peptide, and optionally of CRP (C-reactive protein) in a sample from the subject, calculating (i) a ratio of the amount of IGFBP7 and the amount of the BNP-peptide or (ii) a ratio of the sum of the amounts of IGFBP7 and CRP and the amount of the BNP-type peptide, comparing the ratio calculated with a reference ratio, and differentiating between heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF). The present invention further concerns a method for the diagnosis of HFpEF.
Information query
IPC分类: